Carazolol

Research use only, not for human use.

Carazolol is a high affinityantagonist/partial inverse agonist (also referred to as abeta blocker) of the β-adrenergic receptor.

Carazolol is a high affinityantagonist/partial inverse agonist (also referred to as abeta blocker) of the β-adrenergic receptor.(In Vivo):Carazolol (0.01 mg/kg; i.m.; once) shows no significant side effects.

——

Carazolol (0.01 mg/kg; i.m.; once) shows no significant side effects. Animal Model:Kivircik sheeps, 25-45 kg, nonpregnantDosage:0.01 mg/kg Administration:Intramuscular injection, once Result:Urea, creatinin, ALT, ALP, GGT, LDH, Ca, P, T.Protein, Mg, Cu levels in blood serum parameters were found to be in normal level however serum Fe, Zn levels were decreased.

BM 51052 | (±)-Carazolol

Endocrinology/Hormones

Adrenergic Receptor

β-adrenergic receptor

——

——

57775-29-8

298.38

C18H22N2O2

>98% (HPLC)

Soluble in DMSO

OC(CNC(C)C)COC1=CC=CC(N2)=C1C3=C2C=CC=C3

1-(Carbazol-4-yloxy)-3-(isopropylamino)-2-propanol

(-20℃)

With Ice Pack

≥ 2 years